Valproic Acid and Stevens-Johnson Syndrome: A Vital Warning for Patient Safety

Stevens-Johnson Syndrome is a severe condition that affects the skin and mucous membranes, often caused by medications or infections. Early diagnosis and treatment are crucial for improving outcomes and preventing lasting damage. This case study details the experience of a three-year-old boy who developed SJS after beginning valproate treatment for seizure management following a traumatic brain injury. Initially, he showed fever, facial redness, and a runny nose, which progressed to a severe rash and blisters. The patient is a known case of traumatic brain injury fall from the fifth floor in September 2022— developed seizures after acquired brain injury fall. A dermatologist confirmed the diagnosis of SJS linked to valproate. Swift diagnosis, discontinuation of the offending drug, and supportive care are essential in managing SJS such as IV fluids, wound management, and preventing serious complications. Early intervention and comprehensive care from various medical professionals are crucial for improving patient outcomes. Further research and awareness are essential to understand better the risk factors and mechanisms underlying drug-induced SJS and to improve prevention and treatment strategies.